Woman on miscarriage trial in Birmingham celebrates birth of baby

Nick, Angela and Tom Mummery
Nick, Angela and Tom Mummery

AFTER three traumatic miscarriages in a row, Angela Mummery had practically given up hope of having another child.

But then she heard about a pioneering international trial being carried out on her doorstep in Birmingham and Angela’s despair was transformed into the joy of her baby dreams coming true.

After taking part in the experiment, Angela, of Sycamore Drive, Hollywood, carried the foetus to full term and celebrated the birth of baby son Tom on May 6.

The mum-of-two had a son, Harry, in 2006, but was left unable to carry any more embryos passed three months, something called ‘secondary infertility’, when a woman cannot get pregnant again after having one child.

One of Angela’s friends spotted an article about leading miscarriage doctor Prof Siobhan Quenby working at Heartlands Hospital, in Bordesley Green, where she was carrying out a medical trial, which prompted Angela and teacher husband Nick to take one final chance.

“My problem had never been getting pregnant, it was remaining pregnant,” said Angela, a 40-year-old HR advisor for Solihull Community Housing.

“I was 39 years old and didn’t have a great deal of time left to have children. It’s difficult to keep up hope after losing so many babies.

“The professor told us to go away and to come back when I get pregnant to start the treatment and luckily, I got pregnant within four weeks in August last year.

“In my previous miscarriages, I would go for the 12-week scan and the nurse wouldn’t be able to find a heartbeat. That is immensely tough and heartbreaking.

“I would be sitting in the scan waiting room surrounded by pregnant women knowing that I had lost mine.

“I didn’t think my body would ever be able to support another child.”

The trial involves giving pregnant women with a history of miscarriage the drug Progesterone twice a day, to see if it can help them remain pregnant for nine months.

Progesterone is a steroid hormone produced during pregnancy and given to women having IVF treatment.

Share